Fosciclopirox

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameFosciclopirox
Drug Alias NameCiclopirox phosphoryloxymethyl esterCiclopirox prodrugCPX-POM
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Prodrug
Mechanisms of ActionMitosis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kansas
China Registration ClassN/A

Develop Information

Active CompaniesCiclomed Llc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder Neoplasms
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A